← FDA Drug Approvals (Drugs@FDA)

LIVOSTIN

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1993-11-10

Drug application

FDA Application #

NDA020219

Application type

New Drug Application

Brand name

LIVOSTIN

Generic name

Levocabastine Hydrochloride

Active ingredients

LEVOCABASTINE HYDROCHLORIDE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1993-11-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown